Astria Therapeutics, Inc. Accrued Liabilities, Current
Astria Therapeutics, Inc. had Accrued Liabilities, Current of $16.48 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-11-12
- 2025-09-30: Accrued Liabilities, Current $16.48M.
- 2025-06-30: Accrued Liabilities, Current $15.91M.
- 2025-03-31: Accrued Liabilities, Current $12.34M.
- 2024-12-31: Accrued Liabilities, Current $13.43M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $16.48M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $15.91M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $12.34M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $13.43M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $13.07M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $12.78M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $10.04M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $9.71M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $7.76M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.18M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $5.16M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $7.69M 10-K · filed 2024-03-04 | |
| 2022-09-30 | $5.07M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.66M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $3.85M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $3.28M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $3.58M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.71M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.95M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $4.20M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $4.92M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.69M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.00M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $2.61M 10-K/A · filed 2021-04-19 | |
| 2019-09-30 | $2.48M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.51M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.45M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.76M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $2.73M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.00M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.16M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.43M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $2.74M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.80M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $3.29M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $3.68M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $3.60M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $2.66M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $3.68M 10-Q · filed 2017-05-11 | $2.62M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $3.28M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $2.44M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.56M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $3.28M 10-Q · filed 2016-05-12 | |
| 2014-12-31 | $2.79M 10-K · filed 2016-03-15 |